news

New gene therapy repairs neuron stroke damage in mice

Researchers have developed a new treatment method which turned glial cells into functioning neurons in mice after stroke.

A new gene therapy has turned glial cells into neurons, repairing damage from stroke and improving motor function in mice. The treatment could be used for patients who have suffered from stroke, according to the researchers from Penn State, US.

“I believe that turning glial cells that are already present in the brain into new neurons is the best way to replenish lost neurons,” said Professor Gong Chen, the lead researcher. “These glial cells are the neighbours of the dead neurons in the brain and are likely to share the same ancestral cellular lineage.”

The team previously found that a single genetic neural factor, NeuroD1, could directly convert glial cells into functional neurons inside mouse brains with Alzheimer’s disease, but the number of regenerated neurons was limited.

 

Reserve your FREE place

 


Are you advancing promising antibody leads, only to encounter issues with stability, PK or manufacturability later in development?

30 July 2025 | 10:00 AM BST | FREE Webinar

Join us for an expert-led webinar exploring how early-stage developability assessment can help reduce downstream risk and improve candidate selection.

What You’ll Learn:

  • How to identify key developability risks early including aggregation, PK, and manufacturability
  • How to implement high-throughput in vitro assays requiring <1 mg of antibody per test
  • How to combine in silico modeling with wet-lab analytics to guide early optimisation

Don’t miss your chance to learn from Dr Lei Guo.

Register Now – It’s Free!

 

In the current study, the team utilised the AAV viral system to deliver NeuroD1 into mouse motor cortex that had suffered from stroke.

This is an image of neurons (red) that were converted from glial cells using a new NeuroD1-based gene therapy in a stroke-injured mouse brain (credit: Chen Laboratory, Penn State).

After stroke, surviving glial cells can proliferate and form a glial scar. The AAV system was designed to express NeuroD1 preferentially in the glial cells that form these scars, turning them directly into neuronal cells. The conversion technology not only increased neuronal density in the stroke areas, but also significantly reduced brain tissue loss caused by the stroke.

The researchers found that the newly converted neurons demonstrated similar properties to the neurons that were lost.

“The most exciting finding of this study is to see the newly converted neurons being fully functional in firing repetitive action potentials and forming synaptic networks with other pre-existing neurons,” said Chen. “They also send out long-range axonal projections to the right targets and facilitate motor functional recovery.”

“Because glial cells are everywhere in the brain and can divide to regenerate themselves, our study provides the proof-of-concept that glial cells in the brain can be tapped as a fountain of youth to regenerate functional new neurons for brain repair not only for stroke but also for many other neurological disorders that result in neuronal loss,” said Yuchen Chen, the lead author. “Our next step is to further test this technology and ultimately to translate it into clinically effective therapies to benefit millions of patients worldwide.”

The results were published in Molecular Therapy.